
    
      This is a prospective, non-interventional study (NIS) measuring HRQoL, treatment
      satisfaction, and other PROs of ADPKD patients in Europe. The study aims to enrol at least
      486 patients. Data will be prospectively collected at clinics, from medical notes and via PRO
      measures for each patient at Baseline, Month 1, Month 3 and subsequently at 3 month intervals
      up to and including the final assessment (18 months maximum follow-up time). No visits with
      the patients' treating physician will be imposed by the protocol. Any clinical visits will
      occur as per normal clinical practice
    
  